Several studies have shown that inhibition of ERAP1 causes a profound change in the immunopeptidome able of inducing substantial anti-tumor immune responses by CD8+ T cells and natural killer (NK) cells resulting in the control of tumor growth [20, 23, 24]. This evidence concerns the gene CD8A and neoplasm.